Organigram Holdings Inc. (NASDAQ:OGI - Get Free Report) fell 1.3% on Friday . The company traded as low as $1.53 and last traded at $1.55. 250,374 shares were traded during mid-day trading, a decline of 53% from the average session volume of 534,901 shares. The stock had previously closed at $1.57.
Organigram Trading Down 1.3 %
The firm has a market capitalization of $195.55 million, a P/E ratio of -4.08 and a beta of 1.00. The company has a 50-day moving average of $1.55 and a 200-day moving average of $1.68.
Organigram (NASDAQ:OGI - Get Free Report) last issued its quarterly earnings data on Wednesday, December 18th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.01). Organigram had a negative return on equity of 11.68% and a negative net margin of 28.58%. Research analysts predict that Organigram Holdings Inc. will post -0.09 EPS for the current year.
Institutional Investors Weigh In On Organigram
Institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC raised its stake in Organigram by 40.8% during the second quarter. Renaissance Technologies LLC now owns 816,948 shares of the company's stock worth $1,258,000 after buying an additional 236,700 shares during the last quarter. Toronto Dominion Bank grew its holdings in Organigram by 803.7% during the 3rd quarter. Toronto Dominion Bank now owns 16,727 shares of the company's stock worth $30,000 after acquiring an additional 14,876 shares during the period. Tidal Investments LLC raised its position in shares of Organigram by 8.3% in the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company's stock worth $3,526,000 after acquiring an additional 149,171 shares in the last quarter. Finally, Clear Harbor Asset Management LLC lifted its stake in shares of Organigram by 37.4% in the 4th quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company's stock valued at $72,000 after purchasing an additional 12,250 shares during the period. 34.63% of the stock is owned by institutional investors.
About Organigram
(
Get Free Report)
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Recommended Stories
Before you consider Organigram, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.
While Organigram currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
